Viktoryia Sidarovich
Viktoryia Sidarovich
High Throughput Screening and Validation Core Facility, CIBIO, University of Trento
Verified email at unitn.it - Homepage
TitleCited byYear
A novel mutation in the upstream open reading frame of the CDKN1B gene causes a MEN4 phenotype
G Occhi, D Regazzo, G Trivellin, F Boaretto, D Ciato, S Bobisse, S Ferasin, ...
PLoS genetics 9 (3), e1003350, 2013
772013
Influence of scaffold pore size on collagen I development: A new in vitro evaluation perspective
M Stoppato, E Carletti, V Sidarovich, A Quattrone, RE Unger, ...
Journal of Bioactive and Compatible Polymers 28 (1), 16-32, 2013
402013
Segmental chromosome aberrations converge on overexpression of mitotic spindle regulatory genes in high‐risk neuroblastoma
WF Ooi, A Re, V Sidarovich, V Canella, N Arseni, V Adami, ...
Genes, Chromosomes and Cancer 51 (6), 545-556, 2012
122012
Expression of the plasma prekallikrein gene: utilization of multiple transcription start sites and alternative promoter regions
P Neth, M Arnhold, V Sidarovich, KD Bhoola, E Fink
Biological chemistry 386 (2), 101-109, 2005
72005
TP-0903 inhibits neuroblastoma cell growth and enhances the sensitivity to conventional chemotherapy
S Aveic, D Corallo, E Porcù, M Pantile, D Boso, C Zanon, G Viola, ...
European journal of pharmacology 818, 435-448, 2018
62018
Translational compensation of genomic instability in neuroblastoma.
E Dassi, V Greco, V Sidarovich, P Zuccotti, N Arseni, P Scaruffi, TG Paolo, ...
Scientific reports 5, 14364, 2015
62015
Translational Downregulation of HSP90 Expression by Iron Chelators in Neuroblastoma Cells
V Sidarovich, V Adami, P Gatto, V Greco, T Tebaldi, GP Tonini, ...
Molecular pharmacology 87 (3), 513-524, 2015
52015
A High-Content Screening of Anticancer Compounds Suggests the Multiple Tyrosine Kinase Inhibitor Ponatinib for Repurposing in Neuroblastoma Therapy
V Sidarovich, M De Mariano, S Aveic, M Pancher, V Adami, P Gatto, ...
Molecular cancer therapeutics, 2018
42018
A Cell-Based High-Throughput Screen Addressing 3′ UTR-Dependent Regulation of the MYCN Gene
V Sidarovich, V Adami, A Quattrone
Molecular biotechnology 56 (7), 631-643, 2014
42014
Autophagy inhibition improves the cytotoxic effects of receptor tyrosine kinase inhibitors
S Aveic, M Pantile, P Polo, V Sidarovich, M Mariano, A Quattrone, ...
Cancer Cell International 18 (1), 63, 2018
22018
Multi-omic profiling of MYCN-amplified neuroblastoma cell-lines
E Dassi, V Greco, V Sidarovich, P Zuccotti, N Arseni, P Scaruffi, GP Tonini, ...
Genomics data 6, 285-287, 2015
12015
Genomic Alterations and Abnormal Cell Cycle in High-Risk Neuroblastoma
M Capasso, V Sidarovich, A Quattrone, GP Tonini
Progressive Neuroblastoma 20, 23-34, 2015
2015
High-throughput screening for chemical modulators of post-transcriptionally regulated genes
V Sidarovich, V Adami, A Quattrone
The Journal of Visualized Experiments 97, e52568, 2015
2015
Compounds for treatment of tumors bearing deregulated myc oncoproteins
A Quattrone, V Sidarovich, V Adami
US Patent App. 13/806,880, 2013
2013
Identification of a cis-acting element which assists in the recruitment of alternative transcription start sites/promoters
V Sidarovich, E Fink
Gene 440 (1), 57-62, 2009
2009
Transcription of the human plasma prekallikrein gene: demonstration of alternative promoters, multiple initiation sites, and alternative splicing and identification of cis …
V Sidarovich
Technische Universität München, 2008
2008
The system can't perform the operation now. Try again later.
Articles 1–16